Martingale Asset Management L P Biogen Inc. Transaction History

Martingale Asset Management L P

$4.56 Billion
Q2 2024

A detailed history of Martingale Asset Management L P transactions in Biogen Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 54,341 shares of BIIB stock, worth $9.44 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

54,341

Previous 57,592 5.64%

Holding current value

$9.44 Million

Previous $12.4 Million 1.44%

% of portfolio

0.28%

Previous 0.25%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$190.52 - $236.72 $619,380 - $769,576	-3,251 Reduced 5.64%	54,341 $12.6 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $982,712 - $1.24 Million	-4,635 Reduced 7.45%	57,592 $12.4 Million
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $450,744 - $542,578	-2,025 Reduced 3.15%	62,227 $16.1 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $391,095 - $441,414	1,544 Added 2.46%	64,252 $16.5 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $4,404 - $5,088	-16 Reduced 0.03%	62,708 $17.9 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $9.62 Million - $11 Million	37,482 Added 148.49%	62,724 $17.4 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $8.32 Million - $10.1 Million	-32,978 Reduced 56.64%	25,242 $6.99 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $366,211 - $504,973	1,881 Added 3.34%	58,220 $15.5 Million
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $10.6 Million - $12.6 Million	56,339 New	56,339 $11.5 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $1.95 Million - $2.28 Million	-8,008 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $19.4 Million - $29.2 Million	-82,069 Reduced 91.11%	8,008 $1.96 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $6.99 Million - $8.07 Million	26,409 Added 41.48%	90,077 $25.6 Million
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $16 Million - $21.1 Million	61,708 Added 3148.37%	63,668 $17 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $537 - $682	-2 Reduced 0.1%	1,960 $620,000
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $880,680 - $1.22 Million	-4,002 Reduced 67.1%	1,962 $582,000
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $652,320 - $731,640	-3,000 Reduced 33.47%	5,964 $1.39 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $504,367 - $555,956	-2,300 Reduced 20.42%	8,964 $0
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $557 - $705	2 Added 0.02%	11,264 $3.39 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $146,461 - $191,531	-499 Reduced 4.24%	11,262 $0
Q2 2018 Aug 09, 2018	BUY	$257.52 - $306.91 $51,761 - $61,688	201 Added 1.74%	11,761 $0
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $520 - $735	-2 Reduced 0.02%	11,560 $0
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $29,841 - $33,424	-97 Reduced 0.83%	11,562 $0
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $3.28 Million - $3.84 Million	11,659	11,659 $3.65 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Biogen Inc. Transaction History